These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25324900)

  • 21. The effect of age and the H1c MAPT haplotype on MAPT expression in human brain.
    Hayesmoore JB; Bray NJ; Cross WC; Owen MJ; O'Donovan MC; Morris HR
    Neurobiol Aging; 2009 Oct; 30(10):1652-6. PubMed ID: 18276036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies.
    Labbé C; Heckman MG; Lorenzo-Betancor O; Soto-Ortolaza AI; Walton RL; Murray ME; Allen M; Uitti RJ; Wszolek ZK; Smith GE; Kantarci K; Knopman DS; Lowe VJ; Jack CR; Ertekin-Taner N; Hassan A; Savica R; Petersen RC; Parisi JE; Maraganore DM; Graff-Radford NR; Ferman TJ; Boeve BF; Dickson DW; Ross OA
    Alzheimers Dement; 2016 Dec; 12(12):1297-1304. PubMed ID: 27287057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of MAPT Haplotype H2 and Isoform 1N/4R in Parkinsonism of Older Adults.
    Valenca GT; Srivastava GP; Oliveira-Filho J; White CC; Yu L; Schneider JA; Buchman AS; Shulman JM; Bennett DA; De Jager PL
    PLoS One; 2016; 11(7):e0157452. PubMed ID: 27458716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening non-MAPT genes of the Chr17q21 H1 haplotype in Parkinson's disease.
    Soto-Beasley AI; Walton RL; Valentino RR; Hook PW; Labbé C; Heckman MG; Johnson PW; Goff LA; Uitti RJ; McLean PJ; Springer W; McCallion AS; Wszolek ZK; Ross OA
    Parkinsonism Relat Disord; 2020 Sep; 78():138-144. PubMed ID: 32829096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of the tau haplotype H2 with age at onset and functional alterations of glucose utilization in frontotemporal dementia.
    Laws SM; Perneczky R; Drzezga A; Diehl-Schmid J; Ibach B; Bäuml J; Eisele T; Förstl H; Kurz A; Riemenschneider M
    Am J Psychiatry; 2007 Oct; 164(10):1577-84. PubMed ID: 17898350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide association study stratified by
    Senkevich K; Bandres-Ciga S; Cisterna-García A; Yu E; Bustos BI; Krohn L; Lubbe SJ; Botía JA; ; Gan-Or Z
    medRxiv; 2023 Apr; ():. PubMed ID: 37292720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and functional characterization of H2 haplotype MAPT promoter: unique neurospecific domains and a hypoxia-inducible element would enhance rationally targeted tauopathy research for Alzheimer's disease.
    Maloney B; Lahiri DK
    Gene; 2012 Jun; 501(1):63-78. PubMed ID: 22310385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease.
    Zabetian CP; Hutter CM; Factor SA; Nutt JG; Higgins DS; Griffith A; Roberts JW; Leis BC; Kay DM; Yearout D; Montimurro JS; Edwards KL; Samii A; Payami H
    Ann Neurol; 2007 Aug; 62(2):137-44. PubMed ID: 17514749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology.
    Wider C; Ross OA; Nishioka K; Heckman MG; Vilariño-Güell C; Jasinska-Myga B; Erketin-Taner N; Rademakers R; Graff-Radford NR; Mash DC; Papapetropoulos S; Duara R; Uchikado H; Wszolek ZK; Farrer MJ; Dickson DW
    J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):424-9. PubMed ID: 22291217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition.
    Kauwe JS; Cruchaga C; Mayo K; Fenoglio C; Bertelsen S; Nowotny P; Galimberti D; Scarpini E; Morris JC; Fagan AM; Holtzman DM; Goate AM
    Proc Natl Acad Sci U S A; 2008 Jun; 105(23):8050-4. PubMed ID: 18541914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease.
    Refenes N; Bolbrinker J; Tagaris G; Orlacchio A; Drakoulis N; Kreutz R
    BMC Neurol; 2009 Jun; 9():26. PubMed ID: 19558713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland.
    Kaivorinne AL; Krüger J; Kuivaniemi K; Tuominen H; Moilanen V; Majamaa K; Remes AM
    BMC Neurol; 2008 Dec; 8():48. PubMed ID: 19091059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. H1/H2 MAPT haplotype and Parkinson's disease in Mexican mestizo population.
    Miranda-Morales EG; Sandoval-Carrillo A; Castellanos-Juárez FX; Méndez-Hernández EM; La Llave-León O; Quiñones-Canales G; Ruano-Calderón LA; Arias-Carrión O; Salas-Pacheco JM
    Neurosci Lett; 2019 Jan; 690():210-213. PubMed ID: 30339920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haplotype-specific expression of the N-terminal exons 2 and 3 at the human MAPT locus.
    Caffrey TM; Joachim C; Wade-Martins R
    Neurobiol Aging; 2008 Dec; 29(12):1923-9. PubMed ID: 17602795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease.
    Ertekin-Taner N; Allen M; Fadale D; Scanlin L; Younkin L; Petersen RC; Graff-Radford N; Younkin SG
    Hum Mutat; 2004 Apr; 23(4):334-42. PubMed ID: 15024728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tau (MAPT) haplotypes in Jordan: new evidence on the Middle East as a melting-pot predating Neolithic migration.
    Alkaraki AK; Abuelezz AI; Khabour OF; Peña JA; Alfonso-Sánchez MA; Altaany Z
    Ann Hum Biol; 2021 Aug; 48(5):448-450. PubMed ID: 34538162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease.
    Laws SM; Friedrich P; Diehl-Schmid J; Müller J; Eisele T; Bäuml J; Förstl H; Kurz A; Riemenschneider M
    Mol Psychiatry; 2007 May; 12(5):510-7. PubMed ID: 17179995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synaptic changes in frontotemporal lobar degeneration: correlation with MAPT haplotype and APOE genotype.
    Connelly SJ; Mukaetova-Ladinska EB; Abdul-All Z; Alves da Silva J; Brayne C; Honer WG; Mann DM
    Neuropathol Appl Neurobiol; 2011 Jun; 37(4):366-80. PubMed ID: 21073671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosome 21 BACE2 haplotype associates with Alzheimer's disease: a two-stage study.
    Myllykangas L; Wavrant-De Vrièze F; Polvikoski T; Notkola IL; Sulkava R; Niinistö L; Edland SD; Arepalli S; Adighibe O; Compton D; Hardy J; Haltia M; Tienari PJ
    J Neurol Sci; 2005 Sep; 236(1-2):17-24. PubMed ID: 16023140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The H2 MAPT haplotype is associated with familial frontotemporal dementia.
    Ghidoni R; Signorini S; Barbiero L; Sina E; Cominelli P; Villa A; Benussi L; Binetti G
    Neurobiol Dis; 2006 May; 22(2):357-62. PubMed ID: 16410051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.